Effect of receiving a heart transplant: Analysis of a national cohort entered on to a waiting list, stratified by heart failure severity

BMJ

Volumn 321, Issue 7260, 2000, Pages 540-545

  Deng, Mario C ^a   de Meester, johan m j ^b   Smits, Jacqueline M A ^b   Heinecke, Joachim ^a   Scheld, hans h ^a   Treasure, Tom ^c   Murday, Andrew ^c  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b EUROTRANSPLANT INTERNATIONAL FOUNDATION   (Netherlands)

^c ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; TREATMENT PLANNING;

CLINICAL APPROACH/SOURCE; EMPIRICAL APPROACH; HEALTH CARE AND PUBLIC HEALTH;

ACUTE DISEASE; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GERMANY; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME; WAITING LISTS;

EID: 0037778809     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.321.7260.540     Document Type: Article

References (27)

1. Hunt SA. 24th Bethesda conference: cardiac transplantation. J Am Coll Cardiol 1993; 22: 1-64.
2. Swedberg K for Consensus Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987; 316: 1429-1435.
3. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, et al for the US Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996; 334: 1349-1355.
4. Goldstein DJ, Oz MC, Rose EA. Implantable left ventricular assist devices. N Engl J Med 1998; 339: 1522-1533.
5. Kirsch M, Baufreton C, Naftel DC, Benvenuti C, Loisance DY. Pretransplantation risk factors for death after transplantation: the Henry Mondor experience. J Heart Lung Transplant 1999; 17: 268-277.
6. Hosenpud JD, Bennett LE, Keck BM, Fiol B, Boucek MM, Novick RJ. The Registry of the International Society for Heart and Lung Transplantation: sixteenth official report—1999. J Heart Lung Transplant 1999; 18: 611-626.
7. Edwards EB, Bennett LE, Daily OP, Detre K. Risk of mortality for UNOS status 3 liver recipients: a comparison of the risk posttransplant to the risk on the waiting list. Transplant Proc 1997; 29: 459-460.
8. Hosenpud JD, Bennett LE, Keck BM, Edwards EB, Novick RJ. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 1998; 351: 24-27.
9. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LYC, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725-1730.
10. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med 1987; 317: 141-145.
11. Aaronson KD, Schwartz JS, Chen TMC, Wong KL, Goin JE, Mancini DM. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997; 95: 2660-2667.
12. Lucey MR, Brown KA, Everson GT, Fung JJ, Gish R, Keefe EB, et al. Minimal criteria for placement of adults on the liver transplant waiting list. Transplantation 1998; 66: 956-962.
13. Smits JMA, van Houwelingen HC, de Meester JMJ, Persijn GG, Claas FHJ. Analysis of the renal transplant waiting list. Application of a parametric competing risk method. Transplantation 1998; 66: 1146-1153.
14. De Meester J, Smits JMA, Persijn GG, Haverich A. Lung transplant waiting list: differential outcome of type of end-stage lung disease, one year after registration. J Heart Lung Transplant 1999; 18: 563-571.
15. Byar DP, Simon RM, Friedewald WT, Schlesselman J, DeMets DL, Ellenberg JH, et al. Randomized clinical trials. N Engl J Med 1976; 295: 74-80.
16. Jadad AR, Rennie D. The randomized controlled trial gets a middle-aged checkup. JAMA 1998; 279: 319-320.
17. McGiffin DC, Naftel DC, Kirklin JK, Bourge RC. Advancing knowledge in cardiac transplantation and the place of outcome analysis. Curr Opin Organ Transplant 1998; 3: 44-50.
18. Stevenson LW, Hamilton MA, Tillisch IH, Moriguchi JD, Kobashigawa J, Creaser JA, et al. Decreasing survival benefit from cardiac transplantation for outpatients as the waiting list lengthens. J Am Coll Cardiol 1991; 18: 919-925.
19. Deng MC, DeMeester J, Scheld HH. Development of cardiac transplant policy in Germany. Thorac Cardiovasc Surg 2000; 48: 183-185.
20. Gibbons RD, Meltzer D, Duan N other members of the Institute of Medicine Committee on Organ Procurement and Transplantation. Waiting for organ transplantation. Science 2000; 287: 237-238.
21. Hosenpud JD, Bennett LE, Keck BM, Fiol B, Boucek MM, Novick RJ. The Registry of the International Society for Heart and Lung Transplantation: sixteenth official report—1999. J Heart Lung Transplant 1999; 18: 611-626.
22. Anyanwu AC, Rogers CA, Murday AJ. Review of the current state of thoracic transplantation: a national prospective cohort study. Transplant Proc 1999; 31: 165.
23. The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial. Lancet 1999; 353: 9-13.
24. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet 1999; 353: 2001-2007.
25. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999; 341: 709-717.
26. O'Brien BJ, Buxton MJ, Ferguson BA. Measuring the effectiveness of heart transplant programmes: quality of life and their relationship to survival analysis. J Chronic Dis 1987; 40(suppl 1): 137-58S.
27. Organ donation in the 21st century. London: BMA, 2000.